Lewy Body Dementia Treatment Market Competition Landscape - Key Insights 2018 - 2028 - PowerPoint PPT Presentation

View by Category
About This Presentation

Lewy Body Dementia Treatment Market Competition Landscape - Key Insights 2018 - 2028


Government initiatives aimed at creating awareness about lewy body dementia treatment are likely to uphold growth of the market. – PowerPoint PPT presentation

Number of Views:13
Slides: 10
Provided by: nimittmr
Category: Other


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Lewy Body Dementia Treatment Market Competition Landscape - Key Insights 2018 - 2028

Lewy Body Dementia Treatment Market Forecast,
Trend Analysis Competition Tracking - Global
Market Insights 2018 - 2028
  • Healthcare
  • 17O Pages
  • Published Mar 2019

Market Snapshot
  • The Fact.MR study report on lewy body dementia
    treatment market offers an exhaustive analysis
    and assessment on worldwide lewy body dementia
    treatment market, which has been compiled with
    the aid of a proven and tested research
    methodology that includes primary and secondary
  • This research methodology helped the analysts
    arrive at perceptive insights into the growth
    course of lewy body dementia treatment market
    during the foreseeable period.

Key Insights
  • Global sales of lewy body dementia treatment were
    valued at over US 3,500 Mn in 2018, in line with
    wide-spread prevalence of lewy body dementia and
    subsequent need for effective treatment.
  • Cholinesterase inhibitors, valued at over US
    2,100 Mn in 2018, will continue to remain
    the most lucrative category, followed by
    antipsychotic drugs. The minimal side effects
    associated with these two drug types are among
    the key reasons fuelling demand for these
  • North America will remain the largest market for
    lewy body dementia treatment in 2019 and beyond,
    owing to appropriate dementia drug regulations
    and superior healthcare infrastructure in the

The Competitive Landscape
  • Swedish research-based biopharma company,
    BioArctic AB, announced that AbbVie has attained
    the FDA approval of IND application for ABBV-0805
    for the treatment of individuals with Parkinsons
    disease. The alpha-synuclein-targeting ABBV-0805
    is the most advanced treatment in-licensed by
    AbbVie from BioArctic in December 2018. The
    antibody has been evaluated as a disease
    modifying treatment for Parkinson's disease.
  • Sumitomo Dainippon Pharma Co., Ltd., a
    Japan-based pharmaceutical company, has signed a
    joint research agreement with Aikomi, Ltd. to
    build medical devices to relieve and prevent
    behavioral and psychological symptoms of
  • Takeda Pharmaceutical Company Limited has
    announced the completion of acquisition of Shire
    plc. With this acquisition, Takeda Pharmaceutical
    has become a global, value-based, research and
    development driven biopharmaceutical leader
    headquartered in Japan. 

Table of Contents
  • 1. Executive Summary      1.1. Global Market
    Outlook      1.2. Demand Side Trends      1.3.
    Supply Side Trends            1.4. Indication
    Roadmap      1.5. Analysis and Recommendations
  • 2. Market Overview      2.1. Market Coverage /
    Taxonomy      2.2. Market Definition / Scope /
  • 3. Key Market Trends      3.1. Key Trends
    Impacting the Market      3.2. Drug Innovation /
    Key Development Trends
  • 4. Key Success Factors      4.1. Pipeline
    Assessment      4.2. Disease Treatment
    Pathophysiology      4.3. Key Regulations     
    4.4. Disease Epidemiology

  • 5. Global Lewy Body Dementia Treatment Market
    Demand (in Value or Size in US Mn) Analysis
    2013-2017 and Forecast, 2018-2028      5.1.
    Historical Market Value (US Mn) Analysis,
    2013-2017      5.2. Current and Future Market
    Value (US Mn) Projections, 2018-2028           
     5.2.1. Y-o-Y Growth Trend Analysis           
     5.2.2. Absolute Opportunity Analysis
  • 6. Market Background      6.1. Macro-Economic
    Factors             6.1.1. Global GDP Growth
    Outlook             6.1.2. Global Healthcare
    Expenditure Outlook      6.2. Forecast Factors -
    Relevance Impact             6.2.1.
    Expenditure on RD by Pharmaceutical Companies  
               6.2.2. Cost of Drugs           
     6.2.3. Merger and Acquisitions           
     6.2.4. Collaborative Agreements ..

  • Scope
  • The scope of Fact.MRs report is to analyze the
    Lewy Body Dementia Treatment market for the
    forecast period 2018-2028 and provide readers an
    unbiased and accurate analysis. Lewy Body
    Dementia Treatment manufacturers, stakeholders,
    and suppliers involved in the Lewy Body Dementia
    Treatment market can benefit from the analysis
    offered in this report. This report offers a
    comprehensive analysis, which can be of interest
    to incumbent players and new entrants looking to
    enter the Lewy Body Dementia Treatment market.
  • Summary
  • The report commences with a brief information of
    the Lewy Body Dementia Treatment market. This
    executive summary sets the tone for the rest of
    the report, providing users the scope of the
    report. The executive summary includes important
    facts and statistics on the Lewy Body Dementia
    Treatment market.

Request Free Sample Report
Get In Touch
  • Want Tailor-made Report?
  • Enquire at sales_at_factmr.com Now!
  • Suite 9884 27 Upper Pembroke Street,
    Dublin 2, Ireland
  • Toll Free 353-1-6111-593Email
    sales_at_factmr.comWebsite https//www.factmr.com/
About PowerShow.com